Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17635572 | 0.79 | — | — | |
| SCHEMBL20579051 | 0.79 | CYP2D6 (0.30) | — | |
| SCHEMBL898208 | 0.79 | ALDH1A1 (0.33) | — | |
| SCHEMBL28113803 | 0.79 | ALDH1A1 (0.33) | — | |
| SCHEMBL22047696 | 0.79 | — | — | |
| SCHEMBL22558358 | 0.73 | ALDH1A1 (0.30) | — | |
| SCHEMBL10628137 | 0.72 | TSHR (0.31) | TSHRTDP1 | |
| SCHEMBL31135990 | 0.71 | ALDH1A1 (0.41) | TSHR | |
| SCHEMBL2332271 | 0.71 | DNM1 (0.40) | TSHR | |
| SCHEMBL19522658 | 0.71 | TSHR (0.33) | TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6106994-A | ESTERIFYING A POLYPHENOL COMPOUND AND NAPHTHOQUINONE-1,2-DIAZIDESULFONYL HALIDE IN THE PRESENCE OF FOR EXAMPLE MONOMETHYLDICYCLOHEXYLAMINE, AND POSITIVE PHOTOSENSITIVE COMPOSITION CONTAINS RESULTANT ESTER | TOKYO OHKA KOGYO CO., LTD. (JP) | 2000-08-22 | — | — | US | claimed |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2017-11-02 | — | — | US | disclosed |
| US-9034315-B2 | Cell-charged multi-layer collagen membrane | ED. GEISTLICH SOEHNE AG FUER CHEMISCHE INDUSTRIE (CH) | 2015-05-19 | — | — | US | disclosed |
| US-8858981-B2 | Bone healing material comprising matrix carrying bone-forming cells | Ed. Geistlich Soehne Fuer Chemistrie Industrie (CH) | 2014-10-14 | — | — | US | disclosed |
| US-8354119-B2 | Utilized as a scaffold implant for vertebral or meniscal cartilage regeneration. | ED. GEISTLICH SOEHNE AG FUER CHEMISCHE INDUSTRIE (CH) | 2013-01-15 | — | — | US | disclosed |
| EP-1938845-A2 | Resorbable extracellular matrix for reconstruction of bone | Ed Geistlich Söhne AG Für Chemische Industrie (CH) | 2008-07-02 | — | — | EP | disclosed |
| US-7208177-B2 | Resorbable extracellular matrix for reconstruction of cartilage | ED. GEISTLICH SOEHNE AG FUER CHEMISCHE INDUSTRIE (CH) | 2007-04-24 | — | — | US | disclosed |
| US-20070031388-A1 | Cell-charged multi-layer collagen membrane | ED. GEISTLICH SOEHNE AG FUER CHEMISCHE INDUSTRIE (CH) | 2007-02-08 | — | — | US | disclosed |
| US-20060159668-A1 | Bone healing mixture; collagen matrix and porous bone mineral material | ED. GEISTLICH SOEHNE AG FUER CHEMISTRIE INDUSTRIE (CH) | 2006-07-20 | — | — | US | disclosed |
| US-20030180263-A1 | Resorbable extracellular matrix for reconstruction of bone | ED. GEISTLICH SOEHNE AG FUER CHEMISCHE INDUSTRIE (CH) | 2003-09-25 | — | — | US | disclosed |
| EP-1338291-A2 | Resorbable extracellular matrix for reconstruction of bone | ED. GEISTLICH SÖHNE AG FÜR CHEMISCHE INDUSTRIE (CH) | 2003-08-27 | — | — | EP | disclosed |
| US-20030095994-A1 | Resorbable extracellular matrix containing collagen I and collagen II for reconstruction of cartilage | ED. GEISTLICH SOEHNE AG FUER CHEMISCHE INDUSTRIE (CH) | 2003-05-22 | — | — | US | disclosed |
| EP-1312383-A2 | Resorbable extracellular matrix containing collagen I and collagen II for reconstruction of cartilage | Ed Geistlich Söhne AG Für Chemische Industrie (CH) | 2003-05-21 | — | — | EP | disclosed |
| US-20020090391-A1 | Resorbable extracellular matrix for reconstruction of cartilage | CHEMISCHE INDUSTRIE (CH) | 2002-07-11 | — | — | US | disclosed |
| EP-0352677-B1 | Resin substrate for pigment pastes, its preparation and use | HOECHST AG (DE) | 1996-10-02 | — | — | EP | disclosed |
| US-5066758-A | Cationic polymer for electrodeposition of paints | HOECHST AG (DE) | 1991-11-19 | — | — | US | disclosed |
| EP-0352677-A2 | Resin substrate for pigment pastes, its preparation and use | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-01-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030180263-A1 | Resorbable extracellular matrix for reconstruction of bone | COL2A1, SOST, COL14A1 | TSHR 4654/4885TDP1 4201/4885 |
| US-20060159668-A1 | Bone healing mixture; collagen matrix and porous bone mineral material | COL2A1, BMP2, SOST | TSHR 4796/4885TDP1 4530/4885 |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | HDGF, F11, F12 | TSHR 1973/4885TDP1 4223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.